Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    0815
Show Display Options
Rank Status Study
1 Completed Relapse Prevention With Varenicline
Conditions: Recurrence;   Smoking Cessation;   Substance-Related Disorders
Interventions: Drug: Varenicline;   Drug: Placebo
2 Completed
Has Results
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Drug: Sorafenib;   Drug: Erlotinb
3 Completed Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Conditions: Stable Coronary Artery Disease;   Obesity;   Impaired Glucose Tolerance
Interventions: Other: training;   Other: training + metformin;   Other: training + glitazon
4 Recruiting Technology Enhanced Behavioral Activation Treatment for Substance Use
Conditions: Substance-Related Disorders;   Depressive Disorder;   Behavioral Symptoms;   Risk-Taking;   Sexual Behavior
Interventions: Behavioral: LETS ACT;   Behavioral: LETS ACT-SE;   Behavioral: Treatment as Usual
5 Not yet recruiting Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
Conditions: Hypertension;   Dyslipidemia
Interventions: Drug: Valsartan 160mg + Rosuvastatin 20mg;   Drug: Valsartan 320mg + Rosuvastatin 20mg;   Drug: Diovan® 160mg + Crestor® 20mg;   Drug: Diovan® 320mg + Crestor® 20mg
6 Recruiting Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
Condition: Primacy Immune Thrombocytopenia
Intervention: Drug: Eltrombopag
7 Completed
Has Results
A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: BI: Information-Motivation-Behavioral Skills Model;   Drug: Raltegravir;   Drug: emtricitabine/tenofovir disoproxil fumarate
8 Not yet recruiting The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib
Condition: Hepatocellular Carcinoma
Intervention: Other: telephone counseling
9 Active, not recruiting A Study of Ganetespib in Combination With Chemoradiation
Condition: Esophageal Cancer
Interventions: Drug: Ganetespib;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiotherapy
10 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
11 Active, not recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
12 Recruiting Improving Motor Function After Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Device: rTMS;   Device: Sham rTMS;   Other: Training;   Other: Motor Task
13 Terminated Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
14 Recruiting PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Device: MRI and PET-CT
15 Completed Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BDP/formoterol NEXT DPI
16 Recruiting Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1
Conditions: Pancreatic Carcinoma;   Tumors That Express CA19-9
Interventions: Drug: MVT-2163;   Drug: MVT-5873
17 Completed
Has Results
Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
18 Completed Hypopituitarism After Aneurismal Subarachnoid Hemorrhage
Conditions: Aneurismal Subarachnoid Hemorrhage;   Hypopituitarism;   Neuropsychological Deficits
Intervention:
19 Not yet recruiting Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate
Condition: Immune Thrombocytopenia
Interventions: Drug: Mycophenolate Mofetil;   Drug: Prednisolone
20 Unknown  Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Condition: Blood Loss
Intervention: Device: CM 1500

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.